Romo-Parra H, Blaesse P, Sosulina L, Pape HC. Neurosteroids increase tonic GABAergic inhibition in the lateral section of the central amygdala in mice.
NEUROSTEROIDS, also known as "neuroactive steroids" (Paul and Purdy 1992) , can be synthesized de novo in both neurons and glia from progesterone (Cheney et al. 1995) or deoxycorticosterone (Khisti et al. 2005; Purdy et al. 1991) by the action of the enzymes 5␣-reductase and 3␣-hydroxysteroid dehydrogenase, respectively (Karavolas and Hodges 1991) . A key function of neurosteroids is the modulation of neuronal excitability through interaction with certain neurotransmitter receptors (Lambert et al. 1995; Majewska et al. 1989; Paul and Purdy 1992; Rupprecht 1997; Rupprecht and Holsboer 1999) .
Progesterone metabolites such as 3␣-hydroxy-5␣-pregnan-20-one (allopregnanolone or 3␣,5␣-THPROG) and 3␣,5␣-tetrahydrodeoxycorticosterone (3␣,5␣-THDOC) are among the most potent positive allosteric modulators of type A ␥-aminobutyric acid receptors (GABA A Rs) (Majewska et al. 1989) , and their administration in pharmacological doses elicits anxiolytic, anticonvulsant, and sedative-hypnotic effects in rodents (Majewska 1992) . Specifically, local infusion of allopregnanolone into the rat central nucleus of the amygdala (CeA) produced anxiolytic-like behavioral effects (Akwa et al. 1999) . Thus neuroactive steroids might play a specific role in the modulation of GABAergic transmission in this region and in the regulation of anxiety.
The neurotransmitter GABA can operate in two modes: a "phasic" mode involving the activation of synaptically clustered GABA A Rs by quantal release of GABA and a "tonic" mode mediated by GABA A Rs located extrasynaptically (Farrant and Nusser 2005; Mody 2005) . GABA A Rs are ligandgated chloride (and bicarbonate) channels (Olsen and Sieghart 2009 ) consisting of five subunits that belong to various subunit classes (␣1-␣6, ␤1-␤4, ␥1-␥3, ␦, , , , 1-3) (Barnard et al. 1998; Kumar et al. 2002; Whiting 1999) . Synaptic and extrasynaptic receptors exhibit distinct structural and biophysical properties (Belelli et al. 2009 ). Most GABA A Rs, however, consist of two ␣-, two ␤-, and one ␥-or ␦-subunit (Sieghart and Sperk 2002) . Synaptic GABA A Rs almost invariably incorporate the ␥2-subunit in combination with ␣ (␣1, ␣2, and ␣3)-and ␤2/3-subunit isoforms, while the extrasynaptic receptors are distinct from their synaptic counterparts and are composed of the ␣4-, ␣5-, or ␣6-subunit in combination with ␤-and ␦-subunits (Belelli et al. 2006) .
GABAergic tonic inhibition has been described in many regions of the brain (Farrant and Nusser 2005; Glykys and Mody 2007; Semyanov et al. 2004 ) including the lateral amygdala (LA), the basolateral amygdala (BA; Marowsky et al. 2012) , and the medial section of the CeA (CeAm; Herman et al. 2013) . Besides, so far, three GABA A R subunits have been found to be expressed in mouse CeA: ␣1, ␦, and ␣5, the first two of which were functionally related to the generation of tonic inhibition (Herman et al. 2013) . Neurosteroids act preferentially but not exclusively on the GABA A R ␦-subunit (Brown et al. 2002) . Moreover, changes in the tonic GABA A Rmediated conductance are of high clinical relevance as they are related to schizophrenia, epilepsy, and Parkinson disease (for review see Brickley and Mody 2012) .
The CeA is a primarily GABAergic nucleus and forms the main output station of the amygdala complex, thereby being a critical component of the neurocircuitry underlying stress, fear and anxiety, and pain (Ehrlich et al. 2009; Neugebauer et al. 2004; Pape and Pare 2010) . Not only does the GABAergic system in the amygdala modulate fear and anxiety under physiological conditions, but alterations in this system may also predispose individuals to pathological anxiety traits (Parsons and Ressler 2013; Tasan et al. 2011) .
It has been shown that the neurosteroid allopregnanolone affects phasic GABAergic transmission in CeA neurons by the negative modulation of evoked inhibitory postsynaptic currents (IPSCs), which might involve the activation of NMDA receptors since the effect was occluded by the NMDA receptor antagonist DL-2-amino-5-phosphonovalerate (AP-5) (Wang et al. 2007 ). However, no neurosteroid effects on tonic GABAergic inhibition in CeA have been reported yet.
Here we tested the hypotheses that 1) neurons of the lateral section of the CeA (CeAl) receive tonic GABAergic input mediated by GABA A Rs containing the ␦-subunit and that 2) this tonic inhibition is modulated by the action of neurosteroids.
MATERIALS AND METHODS
All experiments were carried out in accordance with European Communities Council Directive 86/609/EEC. Protocols were approved by the Landesamt für Natur, Umwelt, und Verbraucherschutz Nordrhein-Westfalen (LANUV NRW; AZ 8. 87-50.10.46.09.170 and 87-51-04.2010 .A322).
Slice preparation. As previously described (Kamprath et al. 2011; Sosulina et al. 2010) , C57BL/6J male mice (8 -12 wk old; n ϭ 30) were deeply anesthetized with isoflurane and decapitated. Their brains were rapidly removed and put into oxygenated (95% O 2 -5% CO 2 ) ice-cold artificial cerebrospinal fluid (ACSF) containing (in mM) 120 NaCl, 2.5 KCl, 1.25 NaH 2 PO 4 , 22 NaHCO 3 , 2 MgSO 4 , 2 CaCl 2 , and 10 glucose; pH was 7.4. Coronal slices (250 -300 m thick) were prepared on a vibratome (Leica Microsystems, Wetzlar, Germany) at 4°C. Slices were incubated at 34°C for 20 min and then allowed to equilibrate for at least 1 h at room temperature (RT). After recovery, slices were transferred to a recording chamber continuously superfused with ACSF (ϳ2 ml/min).
Electrophysiological recordings and data analyses. Whole cell (current clamp and voltage clamp) recordings were made at 30°C from the CeAl (Fig. 1A, inset) with an EPC-10 single patch-clamp amplifier (HEKA Elektronik, Lambrecht/Pfalz, Germany). Neurons were visualized by infrared video microscopy (camera CF8/1, Kappa, Gleichen, Germany). Cells were discarded from analysis if the resting membrane potential was more positive than Ϫ50 mV immediately after breaking through the cell membrane. For current-clamp recordings patch pipettes (3-4 M⍀) were filled with an intracellular solution containing (in mM) 95 K ϩ -gluconate, 20 K 3 -citrate, 10 NaCl, 10 HEPES, 1 MgCl 2 , 0.1 CaCl 2 , 1.1 EGTA, 3 Mg-ATP, and 0.5 Na-GTP; pH 7.2 adjusted with 1 M KOH. For each current-clamp experiment, the amplitude of the voltage deflection (V) evoked by the application of negative current injections (I) (Ϫ10 pA, 500 ms) at Ϫ65 mV was measured and the input resistance was calculated based on Ohm's law (R ϭ V/I). To determine excitability action potentials were evoked by positive current injections with varying amplitudes and 500-ms duration. The amplitude of the depolarizing step was adjusted (range 50 -100 pA) to evoke a minimum of two action potentials in an individual cell. Manual clamping was performed by the injection of direct positive current through the recording pipette in order to depolarize the neuron to the membrane potential prior to THDOC application. For voltage-clamp recordings the pipette solution was (in mM) 110 CsCl, 30 K ϩ -gluconate, 1.1 EGTA, 10 HEPES, 0.1 CaCl 2 , 4 Mg-ATP, and 0.3 Na-GTP. Neurons were voltage clamped at Ϫ70 mV, and input and access resistance were determined by analyzing the steady state and transient upon a 10-ms-long 3-mV pulse applied every 20 s, respectively. Access resistance amounted to ϳ4 -9.5 M⍀. Cells were discarded from analysis if the access resistance changed by Ͼ20% over the course of the experiment. Cell capacitance was measured in voltage-clamp mode with a brief (500 ms) 5-mV biphasic voltage step applied immediately after cell membrane rupture. The mean cell capacitance was 75.51 Ϯ 3.52 pF (n ϭ 71), and no differences in cell capacitance were found between the different experimental groups [1-way ANOVA F(10,60) ϭ 1.563; P ϭ 0.1401; n ϭ 11 different experimental conditions]. To correct changes in tonic currents for differences in cell size (cell capacitance), measured currents were converted to current densities [CD ϭ current (pA)/ capacitance (pF) (Marowsky and Vogt 2014; Martin et al. 2014) , and ⌬CD describes the difference between baseline CD and CD in the presence of drugs]. Correction for liquid junction potential changes (10 mV) was applied. Recordings were filtered at 3 kHz (8-pole Bessel filter), sampled at 10 kHz with a gain of 1.0 -1.2 with Patchmaster software (HEKA Elektronik), and analyzed off-line with the programs Mini Analysis (Synaptosoft, Decatur, GA) and Clampfit 10.0 (Molecular Devices, Ismaning, Germany). To isolate the inhibitory currents mediated by GABA A Rs, recordings were made in the presence of the glutamate receptor blockers 6,7-dinitroquinoxaline-2,3-dione (DNQX) and AP-5 and the GABA B receptor antagonist
Baseline was defined from a time frame of 2 min of stable recording under control conditions. Holding current (I hold ) was determined as the current required to maintain the neuron at a holding potential of Ϫ70 mV in the whole cell configuration. The tonic GABA current was calculated and distinguished from IPSCs with a routine written in MATLAB (The MathWorks) in which the mean I hold was obtained by a Gaussian fit to an all-points histogram from 2 min under steady-state conditions. We quantified responses as the difference in I hold between baseline and experimental conditions. Frequency, amplitude, and decay time of isolated spontaneous IPSCs (sIPSCs) were analyzed with a detection threshold of 15 pA with Mini Analysis. All events were visually confirmed, and detection threshold was readjusted in case events were not detected with standard settings. All detected events were used for event frequency analysis, but superimposed events were eliminated for amplitude and decay kinetic analysis as reported previously (Herman et al. 2013) . We determined means of IPSC characteristics from baseline and experimental drug conditions containing a minimum of 60 events in a time period of 2 min under steady-state conditions. Decay kinetics was calculated with monoexponential curve fittings and is reported as half-width decay time (milliseconds).
Immunohistochemistry. Immunohistochemical detection of the GABA A R ␦-subunit was performed with an anti-GABA ␦-subunit antibody (AB9752, Millipore). Staining procedures were similar to those described in a previous study where the specificity of the antibody was confirmed with a GABA A R ␦-subunit-knockout mouse ). In brief, C57BL/6J mice (8 -12 wk old; n ϭ 3 mice) were deeply anesthetized with pentobarbital (50 mg/kg) and perfused transcardially with phosphate-buffered saline (PBS; pH 7.4) followed by 4% paraformaldehyde (in 0.15 M Na-phosphate buffer, pH 7.4). Brains were removed and stored in 4% paraformaldehyde overnight at 4°C. After incubation in 30% sucrose-PBS for cryoprotection, coronal sections (30 m) were cut with a freezing microtome (Frigomobil 1205; Jung, Heidelberg, Germany). Sections were collected in 15% sucrose-PBS, followed by three washes in PBS. After 1-h incubation in 3% H 2 O 2 diluted in methanol, followed by two washes in PBS, sections were blocked for 1 h in 3% bovine serum albumin (BSA), 10% goat serum, and 0.3% Triton in PBS. A guinea pig anti-MAP2 antibody against microtubule-associated protein 2 was obtained from Synaptic Systems (Göttingen, Germany). Antibodies were diluted 1:1,000 in blocking solution. Incubation with agitation was carried out at 4°C overnight. After three wash steps in PBS, sections were transferred to carrier solution (0.3% Triton, 1% BSA, 1% goat serum) and treated with the secondary antibodies goat anti-rabbit conjugated to Alexa Fluor 488 and goat anti-guinea pig conjugated to Alexa Fluor 594 (both diluted 1:1,000, Life Technologies) for 2 h at RT. The fluorescent nuclear stain 4=,6-diamidino-2-phenylindole (DAPI, Sigma-Aldrich; 1:1,000) was added to label cell nuclei. After four additional washes in PBS, sections were mounted with Vectashield HardSet mounting medium (Vector laboratories, Burlingame, CA) and imaged with a laser scanning confocal microscope (Nikon eC1plus) equipped with a CFI75 LWD ϫ16/0.8 NA objective Note that I hold was increased by NNC-711 and this effect was reversed by PTX. D: application of the ␦-subunit-specific agonist THIP (10 M) induced a fast negative shift in I hold followed by a small desensitization reaching a plateau. Subsequently, PTX reversed the THIP effect and caused a significant shift in I hold . E: current trace showing the increase in I hold by application of the GABA A R ␦-subunit agonist DS2 (1 M). Application of PTX shifted I hold to more positive values exceeding baseline. The shifts induced by DS2 and PTX were significant compared with baseline. F: representative data traces showing a positive shift in I hold after application of L-655,708 (500 nM, blocking ␣5-subunit-containing GABA A Rs) and PTX. Application of PTX abolished sIPSCs and caused an additional significant shift in I hold . G: summary data for each pharmacological condition; data were normalized to baseline (last 2 min before drug application) of each single experiment. Significance was tested against control (control ϭ 0). n.s., Not significant. *P Ͻ 0.05, ***P Ͻ 0.001.
finasteride (5 M), and allopregnanolone (5 M) were from Tocris, and THDOC (1 and 10 nM) was from Sigma-Aldrich. Statistical analyses. Because of the variability in I hold among different cells and to clearly show the full drug effect on I hold , we defined the baseline current as 0 for each single experiment and the drug effect was normalized to baseline. We used the one-sample t-test to compare the normalized current and the baseline value 0. A paired two-tailed t-test was used for comparisons made within the same recording with raw data (IPSC parameters), an unpaired two-tailed t-test for comparisons between two different groups, and a one-way ANOVA with Bonferroni's post hoc analysis for comparisons of three or more groups. All statistical analyses were performed with MATLAB, Prism 5.02 (GraphPad Software, San Diego, CA), and Statistica 8 (StatSoft Europe). Data are presented as means Ϯ SE. Statistical significance was accepted if P Ͻ 0.05.
RESULTS

Tonic inhibitory transmission is present in CeA neurons.
GABAergic currents were recorded from visually identified neurons located in the CeAl (Fig. 1A, inset) . The use of CsCl inside the pipette, however, prevented the characterization of the recorded neurons based on their biophysical properties. The CsCl intracellular solutions has a calculated chloride reversal potential of 0 mV; therefore, GABA A R-mediated sIPSCs appeared as fast inward currents at a holding potential of Ϫ70 mV in the presence of NMDA receptor, non-NMDA glutamate receptor, and GABA B R antagonists (see MATERIALS AND METHODS; Fig. 1A ). The frequency of sIPSCs under control conditions was 6.9 Ϯ 0.84 Hz. The GABA A R-mediated tonic conductance was estimated by the shift in the baseline I hold obtained by blocking GABA A Rs with selective antagonists. To isolate the contribution of action potential-dependent vesicular release of GABA from neighboring synapses, we used low concentrations of GBZ, a competitive GABA A R antagonist displacing GABA from its binding site (Hamann et al. 1988) . A concentration of 0.5 M has been reported to selectively abolish spontaneous GABA A R-mediated synaptic currents but not tonic currents (Bai et al. 2001; Semyanov et al. 2003) . In CeAl neurons, GBZ (0.5 M) abolished spontaneous synaptic events (Fig. 1A) and produced a small inward shift of the baseline I hold (⌬I hold ϭ Ϫ2.63 Ϯ 2.3 pA). Normalization to cell size showed no significant change in current density (⌬CD ϭ Ϫ0.035 Ϯ 0.03 pA/pF; 1-sample t-test; P ϭ 0.2628 vs. baseline; n ϭ 11; Fig. 1, A and G) . To subsequently and completely block GABA A R-mediated conductance in the same neurons, we used the GABA A R channel blocker PTX. PTX is an open channel blocker and acts as a noncompetitive GABA A R antagonist that has equivalent efficacy in blocking low-affinity synaptic and high-affinity extrasynaptic GABA A Rs (Stell and Mody 2002) . Thus application of PTX (100 M) on top of GBZ produced an outward shift in I hold (⌬I hold ϭ 57.19 Ϯ 17.38 pA, ⌬CD ϭ 0.9155 Ϯ 0.32 pA/pF; 1-sample t-test, P ϭ 0.0181 vs. baseline; Fig. 1, A and G) , reflecting the blockade of a tonic GABA A Rmediated current. To determine whether or not the induced shift in I hold was due to the generation of action potentialdependent GABA release under basal conditions, we performed the same type of experiment in the presence of TTX (1 M). Under these conditions, action potential-independent miniature IPSCs (mIPSCs) occurred at a frequency of 3.9 Ϯ 0.4 Hz. Application of GBZ blocked mIPSCs and induced an inward shift of I hold (⌬I hold ϭ Ϫ4.2 Ϯ 0.63 pA; ⌬CD ϭ Ϫ0.07108 Ϯ 0.15 pA/pF; 1-sample t-test, P ϭ 0.0031 vs. baseline, n ϭ 7; Fig. 1, B and G) . It should be noted that GBZ also increases the chloride conductance (Bai et al. 2001; Scimemi et al. 2005; Semyanov et al. 2004 ). This inverse antagonist mechanism at low concentrations (0.2-0.5 M; Wlodarczyk et al. 2013) might contribute to the small inward shift in I hold seen in parallel with the expected block of spontaneous synaptic events (Fig. 1A) . In the same seven neurons, the successive application of PTX shifted I hold to more positive values (⌬I hold ϭ 48.6 Ϯ 16.8 pA, ⌬CD ϭ 0.7877 Ϯ 0.24 pA/pF; 1-sample t-test, P ϭ 0.0173 vs. baseline; Fig. 1, B and  G) . The fact that the PTX-induced shift in I hold persisted in the presence of TTX indicates that presynaptic GABA release during spontaneous action potential-dependent network activity is not a major source of ambient GABA mediating the tonic current.
Next, we tested for the effect of an increased ambient GABA concentration. To do so, we applied NNC-711 (5 M), a specific inhibitor of GABA transporter 1 (GAT-1), to block GABA reuptake (Suzdak et al. 1992) . Consistent with previous reports in hippocampus (Holter et al. 2010; Stell and Mody 2002) , NNC-711 shifted I hold to more negative values in six of six cells (⌬I hold ϭ Ϫ19.05 Ϯ 5.96 pA, ⌬CD ϭ Ϫ0.24 Ϯ 0.056 pA/pF; 1-sample t-test, P ϭ 0.0080 vs. baseline; Fig. 1, C and  G) . The addition of PTX in the continuous presence of NNC-711 shifted I hold back to baseline (⌬I hold ϭ 0.1 Ϯ 4.4 pA, ⌬CD ϭ Ϫ0.01 Ϯ 0.05 pA/pF; 1-sample t-test, P ϭ 0.8975 vs. baseline; Fig. 1C ). Hence, while the effect of NNC-711 was small, GAT-1-mediated GABA transport reduced tonic GABAergic inhibition.
GABA A R ␦-subunit is functionally expressed in CeAl neurons. Tonic GABAergic currents are usually mediated by extrasynaptic GABA A Rs containing ␣4-, ␣5-, or ␣6-subunits in combination with ␤-and ␦-subunits (Belelli et al. 2006) . Recent immunohistochemical and electrophysiological data demonstrated the expression of ␣1-and ␦-subunits in the CeAm in mice (Herman et al. 2013) . Because there is evidence that the expression of the ␣1-subunit is much lower in CeAl compared with CeAm (Hortnagl et al. 2013) and because the GABA A R ␦-subunit is the main target of neurosteroid action, we focused on this subunit.
Application of the ␦-subunit-specific agonist THIP hydrochloride (10 M; Krogsgaard-Larsen et al. 2004 ) resulted in an inward shift of I hold in CeAl neurons (⌬I hold ϭ Ϫ125.6 Ϯ 23.2 pA, ⌬CD ϭ Ϫ2.281 Ϯ 0.58 pA/pF; 1-sample t-test, P ϭ 0.0109 vs. baseline, n ϭ 6; Fig. 1, D and G) , providing further evidence that GABA A Rs containing ␦-subunits are involved in the tonic current component. When PTX was added, I hold shifted back to baseline without exceeding it (⌬I hold ϭ 9.72 Ϯ 20.55 pA, ⌬CD ϭ Ϫ0.046 Ϯ 0.35 pA/pF; 1-sample t-test, P ϭ 0.9 vs. baseline; Fig. 1D ).
Furthermore, we tested the effect of the ␦-subunit positive allosteric modulator DS2. At a low concentration (1 M), DS2 shifted I hold to more negative values (⌬I hold ϭ Ϫ13.16 Ϯ 4.7 pA, ⌬CD ϭ Ϫ0.30 Ϯ 0.096 pA/pF; 1-sample t-test, P ϭ 0.0366 vs. baseline, n ϭ 5; Fig. 1, E and G) . The addition of PTX shifted I hold to more positive values not different from baseline (⌬I hold ϭ 6.4 Ϯ 5.4 pA, ⌬CD ϭ 0.2104 Ϯ 0.1391 pA/pF; 1-sample t-test, P ϭ 0.2048 vs. baseline, n ϭ 4; Fig. 1E ).
While the GABA A R ␦-subunit is the most relevant subunit in terms of neurosteroid action, we also checked for the contribution of the ␣5-subunit to tonic inhibition in CeAl neurons, using the ␣5-subunit partial inverse agonist L-655,708 (500 nM) (Prenosil et al. 2006; Quirk et al. 1996) . While L-655,708 had no effect in the CeAm (Herman et al. 2013) , bath application of this drug induced a small but significant effect on I hold in CeAl neurons (⌬I hold ϭ 15.2 Ϯ 1.6 pA, ⌬CD ϭ 0.3207 Ϯ 0.82 pA/pF; 1-sample t-test, P ϭ 0.030 vs. baseline, n ϭ 4; Fig.  1, F and G ). An only minor contribution of the ␣5-subunit is in line with a rather low expression level of this subunit in the CeA (Marowsky et al. 2012; Pirker et al. 2000; Prut et al. 2010 ; but see Hortnagl et al. 2013) . A summary of the pharmacological effects is depicted in Fig. 1G .
In agreement with the functional data ( Fig. 1 ) and previous studies, immunostaining confirmed the expression of the ␦-subunit in the CeA, with a stronger signal in CeAl compared with CeAm (Fig. 2, A-D) . Indicating specificity of the staining, strong GABA A R ␦-subunit labeling was seen in the dentate gyrus ( Fig. 2E ; Maguire et al. 2009 ).
Neurosteroids increase I hold in CeAl neurons. The progesterone metabolites THDOC and allopregnanolone induce opening of the GABA A receptor channel at nanomolar concentrations in vitro (Lambert et al. 1995; Majewska 1992) , acting preferentially, but not exclusively, on ␦-containing subunit assemblies of tonic GABA A Rs (Brown et al. 2002; Stell et al. 2003) . To determine the effect of neurosteroids on GABAergic tonic inhibition, we tested THDOC and allopregnanolone in the presence of ionotropic glutamate receptor antagonists and GABA B R inhibition.
Superfusion of THDOC (10 nM) produced a significant negative shift in baseline I hold (⌬I hold ϭ Ϫ68.76 Ϯ 19.6 pA, ⌬CD ϭ Ϫ1.4 Ϯ 0.52 pA/pF; 1-sample t-test, P ϭ 0.0295 vs. baseline, n ϭ 8; Fig. 3, A and O) . This effect was reversed by the subsequent application of PTX in eight of eight cells recorded (Ϫ26.78 Ϯ 20.38 pA, ⌬CD ϭ 0.75 Ϯ 0.56 pA/pF; 1-sample t-test, P ϭ 0.2271 vs. baseline; Fig. 3A) . Interestingly, the THDOC-induced ⌬CD was almost as big as the ⌬CD induced by THIP (Ϫ2.281 Ϯ 0.58 pA/pF; see Fig. 1G ; unpaired t-test, P ϭ 0.1066). At this concentration, THDOC affected sIPSCs by increasing the half-width decay time (control: 14.6 Ϯ 2.0 ms, THDOC: 27.7 Ϯ 5.8 ms; paired t-test, P ϭ 0.0396; Fig. 3, B and C) , without changing sIPSC instant frequency (control: 3.1 Ϯ 0.6 Hz, THDOC: 2.4 Ϯ 0.7 Hz; paired t-test, P ϭ 0.1172; Fig. 3D ) and sIPSC amplitude (control: 42.7 Ϯ 11.4 pA, THDOC: 38.3 Ϯ 6.3 pA; P ϭ 0.5541; Fig. 3E ). Similar effects have been previously observed in hippocampal neurons (Belelli et al. 2006; Belelli and Lambert 2005; Jo et al. 2011 ). The THDOC-induced changes in I hold were not prevented by the preceding application of TTX (⌬I hold ϭ Ϫ59.5 Ϯ 18.6 pA, ⌬CD ϭ 0.9 Ϯ 0.33 pA/pF; 1-sample t-test, P ϭ 0.0412 vs. baseline, n ϭ 6; Fig. 3, F and  O) , suggesting that the effects of THDOC are not mediated by the generation of action potential-dependent GABA release under basal conditions. This increase was reversed by the successive application of PTX (⌬I hold ϭ 22.1 Ϯ 4.9 pA, ⌬CD ϭ 0.5036 Ϯ 0.2127 pA/pF; 1-sample t-test, P ϭ 0.0987 vs. baseline; Fig. 3G ). Furthermore, a low dose of THDOC (1 nM), which is considered to be below physiological plasma concentrations (ϳ8 nM) (Stell et al. 2003) , was sufficient to increase I hold (⌬I hold ϭ Ϫ26.5 Ϯ 4.9 pA, ⌬CD ϭ Ϫ0.5213 Ϯ 0.94 pA/pF; 1-sample t-test, P ϭ 0.0117, n ϭ 5; Fig. 3 , G and O), but to a lesser extent than 10 nM (10 nM THDOC vs. 1 nM THDOC, unpaired t-test, P ϭ 0.0065).
Next we tested the effect of allopregnanolone on I hold in CeAl neurons. Bath application of allopregnanolone (5 nM) induced a negative shift in I hold (⌬I hold ϭ Ϫ22.53 Ϯ 9.1 pA, ⌬CD ϭ Ϫ0.2942 Ϯ 0.088 pA/pF; 1-sample t-test, P ϭ 0.0202, n ϭ 6; Fig. 3H ), without affecting sIPSC half-width decay time (control: 8.8 Ϯ 0.7 ms, allopregnanolone: 13.3 Ϯ 4.7 ms; paired t-test, P ϭ 0.6905; Fig. 3, I and J), sIPSC instant frequency (control: 5.0 Ϯ 1.1 Hz, allopregnanolone: 5.1 Ϯ 0. 5 Hz; paired t-test, P ϭ 0.6250; Fig. 3K ), or sIPSC amplitude (control: Ϫ46.1 Ϯ 12.0 pA, allopregnanolone: 40.2 Ϯ 10.2 pA; paired t-test, P ϭ 0.0625; Fig. 3L ). The effect on I hold was reversed by the application of PTX, which shifted I hold back to baseline in all six neurons tested (⌬I hold ϭ 1.633 Ϯ 4.65 pA, ⌬CD ϭ 0.4236 Ϯ 0.057 pA/pF; 1-sample t-test, P ϭ 0.4940; Fig. 3H ). The blockade of action potentials by TTX did not prevent the allopregnanolone-induced effects (⌬I hold ϭ Ϫ42.7 Ϯ 13.3 pA, ⌬CD ϭ Ϫ0.4567 Ϯ 0.1496 pA/pF; 1-sample t-test, P ϭ 0.0117, n ϭ 5; Fig. 3M ). In the same neurons, the successive application of PTX reduced I hold and reversed the effect produced by allopregnanolone (⌬I hold ϭ 58.78 Ϯ 21.6 pA, ⌬CD ϭ 0.67 Ϯ 0.28 pA/pF; 1-sample t-test, P ϭ 0.0960, n ϭ 5; Fig. 3M ), suggesting that the allopregnanolone effect is due to the activation of nonsynaptic GABA A Rs. The amplitude of the allopregnanolone effect might be underestimated because of the rather low concentration used (5 nM). However, it has been shown that high doses of allopregnanolone (300 nM) have a direct effect on chloride channels (Twyman and Macdonald 1992) , and such an effect would lead to changes in I hold .
It is known that the biosynthesis of THDOC and allopregnanolone is limited by the 5␣-reductase pathway (Sanna et al. 2004) . To test whether or not the inhibition of biosynthesis of neurosteroids would affect tonic GABAergic inhibition, we bath applied finasteride, a specific inhibitor of the 5␣-reductase (Finn et al. 2006; Scarduzio et al. 2013) . Finasteride application induced a trend toward an increased IPSC decay half-width (control: 14.48 Ϯ 2.33 ms, finasteride: 21 Ϯ 1.84 ms; P ϭ 0.0522; n ϭ 5), which, however, was not significant. In addition, neither the frequency (P ϭ 0.9932) nor the amplitude (P ϭ 0.8133) of the sIPSCs was affected by finasteride. Furthermore, as expected, finasteride (5 M) was able to partially reduce I hold (⌬I hold ϭ 9.6 Ϯ 1.3 pA, ⌬CD ϭ 0.1274 Ϯ 0.03 pA/pF; 1-sample t-test, P ϭ 0.0050; time of onset of finasteride effect: 7.57 Ϯ 0.74 min; n ϭ 7; Fig. 3N ).
The application of PTX on top of finasteride further decreased I hold (⌬I hold ϭ 21.47 Ϯ 3.76 pA, ⌬CD ϭ 0.29 Ϯ 0.09 pA/pF; 1-sample t-test, P ϭ 0.0159 vs. baseline). These data suggest that neurosteroids are locally synthesized. Figure 3O shows a quantitative summary of the neurosteroid and finasteride effects. THDOC hyperpolarizes CeAl neurons. To test the effect of THDOC on the membrane potential and action potential activity, we recorded CeAl neurons under current-clamp conditions. Neurons were held at approximately Ϫ65 mV through direct current injection to minimize variability in membrane resting potential and resulting driving forces. Action potentials were evoked by a depolarizing square pulse every 20 s (see MATERIALS AND METHODS). THDOC (10 nM) induced a hyperpolarization of the membrane potential resulting in a block of action potentials and reaching steady state after ϳ20 min (hyperpolarization from Ϫ63.21 Ϯ 0.9 mV to Ϫ69.34 Ϯ 1.9 mV; paired t-test, P ϭ 0.0286, n ϭ 4; Fig. 4, A-C) . Bringing back the membrane potential to preapplication level through injection of positive current [manual clamping (MC) to Ϫ63.08 Ϯ 1.0 mV] during near-maximal effects of THDOC confirmed that the injection of positive current was not able to induce action potentials (Fig. 4, A-C) . The apparent input resistance was significantly decreased by THDOC [control: 477.3 Ϯ 35.11 M⍀, THDOC: 237.2 Ϯ 19.84 M⍀, MC: 247.2 Ϯ 19.8 M⍀, post-MC: 267.1 Ϯ 25.6 M⍀; 1-way ANOVA F(3,16) ϭ 21.93, P Ͻ 0.0001, n ϭ 4; Fig. 4D] . A Bonferroni's multiple-comparison test revealed differences between control and THDOC (t ϭ 6.969, P Ͻ 0.05), MC (t ϭ 6.979, P Ͻ 0.05), and post-MC (t ϭ 6.102, P Ͻ 0.05), indicating that the membrane conductance was increased by THDOC application leading to a reduction in excitability.
DISCUSSION
In the present study, we show that a tonic GABAergic current mediated by GABA A Rs containing the ␦-subunit is present in neurons of the CeAl and that this current is under the control of the neurosteroids THDOC and allopregnanolone. According to the converging immunohistochemical and pharmacological evidence provided here, the GABA A R ␦-subunit contributes substantially to the tonic inhibition in the CeAl. In detail, the ␦-subunit was detected at the protein level in the Fig. 3 . Neurosteroids modulate tonic GABAergic inhibition in CeAl neurons. A: current trace showing the increase of the tonic current induced by the neurosteroid tetrahydrodeoxycorticosterone (THDOC, 10 nM). The effect was reversed by PTX. B: sIPSCs (mean of 10 traces) recorded at Ϫ70 mV in control and after application of THDOC (10 nM) displaying the increase in decay time. C-E: decay time half-width (C), instant frequency (D), and amplitude (E) of sIPSCs before (black) and after (white) THDOC application. While decay time was increased by THDOC, instant frequency and amplitude remained unaffected. F: same as in A but in the continuous presence of TTX. Note that the effect of THDOC on the neuron recorded was a postsynaptic effect since TTX did not prevent the increase in I hold . G: even at a low concentration of 1 nM, THDOC was effective in enhancing the tonic current. H: current traces showing the increase in the tonic current induced by the neurosteroid allopregnanolone (ALLO, 5 nM). This effect was reversed by the successive application of PTX. I: sIPSCs (mean of 10 traces) recorded at Ϫ70 mV in control and after the application of allopregnanolone. J-L: decay time half-width (J), instant frequency (K), and amplitude (L) of sIPSCs. Note that although allopregnanolone increased the decay time this was not significantly different from control (paired t-test, P ϭ 0.6905). M: same as in H but under the blockade of action potentials by TTX. N: representative current traces showing a positive shift in I hold after application of the 5␣-reductase inhibitor finasteride (FIN) and PTX. Application of PTX caused an additional significant shift in I hold . O: summary of the different pharmacological conditions: effects of THDOC, allopregnanolone, and finasteride on tonic inhibitory currents. Data were normalized to baseline (last 2 min before drug application) of each single experiment, and significance was tested against control (control ϭ 0). *P Ͻ 0.05, **P Ͻ 0.01. CeA when using a knockout-tested ␦-subunit-specific antibody ). Furthermore, in vitro application of the specific GABA A R ␦-subunit agonist (THIP) and the nonselective GABA A R ␦-subunit modulator (DS2) significantly evoked a tonic GABAergic current in CeAl neurons. It is known that two subunit-specific forms of tonic inhibition exist in CeAm neurons in mouse and rat (Herman et al. 2013; Herman and Roberto 2014) . A sustained tonic conductance mediated by the GABA A R ␣1-subunit is present in mouse neurons expressing corticotropin-releasing factor (CRF) receptor-1 (CRF1R). CRF1R-negative neurons, however, possess no intrinsic tonic inhibition but demonstrate a ␦-subunitmediated tonic conductance in the presence of an increased local GABA concentration (Herman et al. 2013) . In contrast, we did not find any cell type specificity in the CeAl since all the neurons recorded displayed an ongoing and ␦-subunitmediated tonic GABAergic current. GABAergic tonic inhibition has also been shown in LA and BA, where it is mediated by GABA A Rs containing the ␣3-subunit and where the expression of the ␦-subunit is rather low (Marowsky et al. 2012) . The evidence for ␦-subunit-mediated tonic GABAergic inhibition in CeAl neurons is in agreement with the observed strong effect of the neurosteroids THDOC and allopregnanolone. Interestingly, in paracapsular cells of the amygdala, which are also known to express GABA A Rs containing the ␦-subunit, THDOC (at a concentration of 300 nM) affected the tonic current only when applied in combination with 5 M GABA (Marowsky and Vogt 2014) , suggesting that CeAl neurons are a dominant target of neurosteroid action within the amygdala. PTX clearly unmasked an intrinsic tonic current in (e.g., Fig. 1,  A and B) as indicated by the induced outward current. However, when PTX was applied successively to drugs that induced a strong increase in the tonic current (e.g., THIP and THDOC; Fig. 1D and Fig. 3A, respectively) , PTX still induced a shift in I hold back to baseline, but without exceeding it. While similar effects have been seen elsewhere (Herman et al. 2013; Jo et al. 2011; Kolbaev et al. 2012 ), a clear explanation for this phenomenon is missing. One possible explanation is that the activation of ␦-subunit-containing GABA A Rs by drugs like THIP and THDOC directly or indirectly also leads to an activation of a PTX-insensitive non-GABAergic conductance.
Changes in neurosteroid levels (e.g., during the ovarian cycle) and the consequent changes in tonic GABAergic signaling via ␦-subunit-containing GABA A Rs have been linked to an altered seizure susceptibility and to anxiety (Maguire et al. 2005) . Similarly, a reduction of endogenous THDOC and allopregnanolone levels has been found to lower the potency of GABA in eliciting GABA A R-mediated IPSCs (Barbaccia 2004; Dong et al. 2001) . In the present study, THDOC hyperpolarized CeAl neurons, thereby decreasing their excitability. The CeAl neurons are mutually interconnected via GABAergic synapses, and they connect to the CeAm. An enhancement of tonic GABAergic inhibition in the CeAl might thus result in either an inhibitory or a disinhibitory overall influence on CeAm output neurons. In addition, modulatory effects of THDOC on tonic GABAergic currents are context dependent. For the hypothalamic-pituitary-adrenal (HPA) axis it has been shown that THDOC potentiates the inhibitory action of GABA on CRF neurons under control conditions, whereas THDOC activates the HPA axis after stress (Sarkar et al. 2011 ). This change in the direction of the THDOC effect on network activity is due to a stress-induced collapse of the chloride gradient in CRF neurons that results in an excitatory action of GABA (Sarkar et al. 2011) .
Behaviorally, a reduction of endogenous THDOC and allopregnanolone levels is related to anxiety-like responses, increased aggression, and a reduced sensitivity to the loss of righting reflex induced by GABA A R agonists or positive modulators, but also to an enhanced expression of fear conditioning responses in rodents. Conversely, enhanced neurosteroid action results in anxiolysis, sedation/hypnosis, and anticonvulsant and anesthetic action (Barbaccia 2004) . Furthermore, increases in contextual fear can be abolished by treatment with drugs that normalize the corticolimbic levels of allopregnanolone (AgisBalboa et al. 2009 ). Therefore the enhancement of tonic inhibition through neurosteroid action in the CeAl is likely to reduce activity in CeAm neurons mediating fear responses.
Inhibition of the synthesis of neurosteroids with finasteride, a specific inhibitor of the 5␣-reductase (Finn et al. 2006; Scarduzio et al. 2013 ), led to a decrease in the tonic GABAergic current in CeAl neurons. Although the bath application of finasteride does not reveal the cellular source of the neurosteroids, the observed effect indicates that there is an ongoing local neurosteroid synthesis. While we cannot fully exclude nonspecific effects of finasteride on other ligands or conductances, additional evidence for the local synthesis is provided by the demonstration of immunoreactivity of neurosteroids (Saalmann et al. 2007; Tokuda et al. 2010 ) and 5␣-reductase type II expression (Castelli et al. 2013 ) in neurons of the amygdala. Interestingly, mice with enhanced contextual fear responses and impaired fear extinction show decreased 5␣-reductase type I mRNA expression and allopregnanolone levels in the amygdala and other brain regions (Pibiri et al. 2008) .
The combination of rapid local neurosteroid synthesis and GABA potentiation makes the neurosteroid system a target for local modulation of GABAergic inhibition, thereby contributing to synaptic plasticity. In line with this, finasteride has an effect on fear learning (Disney and Calford 2001) . In addition, midazolam (a benzodiazepine acting on GABA A Rs) enhances a specific form of network inhibition and inhibits long-term potentiation and contextual fear learning, an effect that is blocked when finasteride is administrated 1 day before midazolam (Tokuda et al. 2010 ). The present study provides for the first time evidence that finasteride is able to decrease tonic inhibition in CeA neurons.
GABA A Rs containing the ␣5-subunit contribute to tonic inhibition only when the ambient GABA concentration increases but are not activated by endogenous ambient GABA (Scimemi et al. 2005) . The majority of CeAl neurons are GABAergic cells (Ehrlich et al. 2009; Haubensak et al. 2010 ), which could contribute to an enhanced ambient GABA concentration. A higher ambient GABA concentration in CeAl versus CeAm would explain the small ␣5-subunit-mediated tonic current in CeAl, which is completely absent in CeAm (Herman et al. 2013) . Furthermore, Li et al. (2013) suggested that excitatory synapses onto somatostatin-positive neurons in CeAl are strengthened while the somatostatin-negative neurons are weakened after fear conditioning. Because the somatostatin-positive neurons are forming intra-CeAl GABAergic synapses, an increased activity of these neurons might result in higher extracellular GABA levels. Thus, while activation of ␦-subunit-containing GABA A Rs predominates at low ambi-ent GABA concentrations, ␣5 subunit-containing GABA A Rs would be activated after fear conditioning.
It has been suggested that synaptic spillover after vesicular release (Attwell et al. 1993) , reversal of GABA transporters (Gaspary et al. 1998) , and a GABA "leak" through bestrophin channels (Lee et al. 2010 ) are sources of ambient GABA. As shown recently, reactive astrocytes seem to produce and release GABA through bestrophin channels under pathological conditions (Jo et al. 2014) . Active uptake maintains GABA at sufficiently low concentrations to prevent tonic GABA B R activation (Isaacson et al. 1993) . The enhanced tonic GABAergic current seen in CeAl neurons after the application of NNC-711, a selective inhibitor of GABA uptake by GAT-1, confirms the presence of active GABA uptake but excludes reverse GABA transport as a source of extracellular GABA under these conditions. It should be noted that the effect of NNC-711 was relatively small, which might be due to a relatively high ambient GABA level in the CeAl (see above).
In conclusion, here we provide evidence that CeAl neurons contain GABA A Rs that mediate inhibitory tonic currents that are likely attributable to the expression of the GABA A R ␦-subunit. Furthermore, we show that these tonic currents are modulated by neurosteroids and play an important role in regulating the excitability of CeAl neurons. As a consequence, the tonic GABAergic current and the neurosteroid-mediated regulation may be potential targets for a pharmacological manipulation of the imbalance in the amygdala output underlying anxiety disorders.
